Discovering Protein-targeted Antitumor Inhibitors: Drug Screening Strategy and Molecular Mechanisms

Curr Pharm Biotechnol. 2022;23(14):1636. doi: 10.2174/138920102314220903160910.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antineoplastic Agents* / pharmacology
  • Antineoplastic Agents* / therapeutic use
  • Cell Line, Tumor
  • Drug Evaluation, Preclinical
  • Drug Screening Assays, Antitumor
  • Molecular Structure
  • Protein Kinase Inhibitors
  • Structure-Activity Relationship

Substances

  • Antineoplastic Agents
  • Protein Kinase Inhibitors